- Cronos Group fell as much as 5% in early Thursday trading despite surpassing the highest analyst estimate for second-quarter revenue.
- The company attributed its quarterly success to the newly launched adult-use market in Canada and increased interest in cannabis oil.
- Cronos’ second quarter saw its acquire CBD-distributor Redwood Holding Group, hire Mondelez veteran Dr. Todd Abraham as chief innovation officer, and open a new RD facility in Israel.
- Watch Cronos trade live here.
Cronos Group stock dropped as much as 5% in early trading Thursday despite surpassing the highest analyst estimate for its